Reply to Viel

Affiliations

¹ CytoDyn, Vancouver, Washington, USA.
² Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
³ Arthritis & Rheumatic Disease Specialties, Aventura, Florida, USA.
⁴ Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.
⁵ Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, USA.

Comment

Christopher Recknor et al. Clin Infect Dis. 2022.

. 2022 Oct 12;75(8):1486-1487.

doi: 10.1093/cid/ciac390.

¹ CytoDyn, Vancouver, Washington, USA.
² Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
³ Arthritis & Rheumatic Disease Specialties, Aventura, Florida, USA.
⁴ Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.
⁵ Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, USA.

No abstract available

Comment on

Response to 'Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome'.
Viel KR. Viel KR. Clin Infect Dis. 2022 Oct 12;75(8):1485-1486. doi: 10.1093/cid/ciac389. Clin Infect Dis. 2022. PMID: 35819236 Free PMC article. No abstract available.